All news
-
7 Nov 2022
MultiPark researcher with Bill Gates in Brussels
MultiPark’s scientists conduct world-leading research in biomarkers for Alzheimer’s disease, led by Professor Oskar Hansson at the memory clinic at Skåne University Hospital. He re...
-
28 Oct 2022
Modelling Parkinson’s disease – PhD interview with Matilde Negrini
Matilde Negrini’s thesis project has been to develop and characterize a rat model of Parkinson’s disease. November 4, she defends her thesis. Here, she talks about her project and ...
-
24 Oct 2022
Does the Mediterranean diet really decrease your risk of dementia?
Numerous studies have suggested that eating a healthy diet may reduce a person’s risk of dementia. A new study from one of MultiPark's research groups, published in Neurology, shed...
-
21 Oct 2022
Swedish Medical Products Agency grants approval for clinical study of new stem cell based Parkinson’s Disease treatment
An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval ...
-
7 Oct 2022
Turning glia into neurons inside the brain – PhD interview with Jessica Giacomoni
Cell replacement therapy has long been a hope for patients with Parkinson’s disease and efforts are on their way to use stem cell derived-dopaminergic neurons in clinical trials. O...
-
5 Oct 2022
Biomarker reveals inflammatory changes in the brain with Alzheimer’s disease
Inflammatory responses in the brain have long been suspected of playing a role in Alzheimer’s disease, but are challenging to monitor in the living human brain. An international co...
-
28 Sep 2022
Malin Parmar elected to the Royal Swedish Academy of Sciences
The Royal Swedish Academy of Sciences has elected two new members of the Academy’s class for medical sciences. One of them is Malin Parmar, Professor of Cellular Neuroscience at Lu...
-
14 Sep 2022
MultiPark Debate – Aducanumab (YES/NO)
What is the best approach for treating Alzheimer's disease? Aducanumab is an amyloid beta-directed monoclonal antibody that targets the aggregated forms of amyloid beta found in th...
-
12 Sep 2022
MultiPark researcher behind Alzheimer's Association Recommendations about use of Alzheimer's "Blood Tests"
Alzheimer's Association recently released recommendations about using blood-based biomarkers to detect Alzheimer’s disease. The recommendations are based on research conducted by O...
-
31 Aug 2022
Inflammation and the glymphatic system – Ph.D. interview with Marta Ramos
Marta Ramos’ Ph.D project unravels how inflammation and the glymphatic system affect each other in the brain. September 9, she defends her thesis. Here, she explains how you may co...
-
22 Aug 2022
Researchers reprogram human skin cells to aged neurons to study neurodegenerative disorders
Researchers at Lund University in Sweden have developed a new method for studying age-related brain disorders. The researchers have focused on the neurodegenerative disorder Huntin...
-
9 Aug 2022
How our skin cells might be the key to better understanding the human brain
Researchers from Lund University interested in understanding how aging affects the brain have made a new discovery that will help make it easier to study age-related brain diseases...
-
30 Jun 2022
Summer greetings!
-
27 Jun 2022
Looking at the long, magnificent road of a neuroscientist’s life - an interview with Anders Björklund
Life is like a marathon. According to Dr. Anders Björklund, a pioneer and expert in cell replacement strategies for patients with Parkinson’s Disease, so is life in academia. Along...
-
13 Jun 2022
Awardees of the 2022 Bundy Academy Major Prize
The Bundy Academy’s 2022 major prize amounting to SEK 3 million is awarded to Sebastian Palmqvist, Associate Professor of Clinical Memory Research at Lund University and Senior Phy...
-
1 Jun 2022
The glymphatic system – PhD interview with Nicholas Bèchet
The glymphatic system, which helps clear waste products from the brain, was discovered about a decade ago. Nicholas Bèchet’s project shines light on how it works in Alzheimer’s dis...
-
30 May 2022
MultiPark provides safe places for Ukrainian researchers
Since 24 February, nothing has been the same for Ukrainian researchers. In this urgent situation, MultiPark has offered some of them a sanctuary. They are eager to share their thou...
-
24 May 2022
Psychiatric symptoms in Alzheimer´s disease
In addition to memory problems and other cognitive symptoms, most people with Alzheimer’s disease also suffer from mental health issues. It has long been unclear whether these occu...
-
18 May 2022
Huntington’s – a complex brain disease that affects movement, thoughts and feelings
Huntington’s disease is hereditary, genetic and usually begins between the ages of 30 and 50. In Sweden, around 1,000 people have the diagnosis and several thousand live with the r...
-
13 May 2022
Special interest groups open up for more collaboration within MultiPark
The MultiPark backbone for research interactions is about to be reorganized. Thanks to our members' suggestions, we are now creating 13 special interest groups to address important...